The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants

Neurobiology of Aging

Volumn 35, Issue 1, 2014, Pages 266.e5-266.e14

  Heckman, Michael G ^a   Elbaz, Alexis ^b,c   Soto Ortolaza, Alexandra I ^d   Serie, Daniel J ^a   Aasly, Jan O ^e   Annesi, Grazia ^f   Auburger, Georg ^g   Bacon, Justin A ^d   Boczarska Jedynak, Magdalena ^h   Bozi, Maria ⁱ   Brighina, Laura ^j   Chartier Harlin, Marie Christine ^b,k   Dardiotis, Efthimios ^l,m   Destée, Alain ^b,k,n   Ferrarese, Carlo ^j   Ferraris, Alessandro ^o   Fiske, Brian ^p   Gispert, Suzana ^g   Hadjigeorgiou, Georgios M ^l,m   Hattori, Nobutaka ^q   Ioannidis, John P A ^r,s   Jasinska Myga, Barbara ^h   Jeon, Beom S ^t   Kim, Yun Joong ^u   Klein, Christine ^v   Kruger, Rejko ^w   Kyratzi, Elli ^x   Lin, Chin Hsien ^y   Lohmann, Katja ^v   Loriot, Marie Anne ^b,z,aa   Lynch, Timothy ^ab   Mellick, George D ^ac   Mutez, Eugénie ^b,k,n   Opala, Grzegorz ^h   Park, Sung Sup ^t   Petrucci, Simona ^o   Quattrone, Aldo ^ad   Sharma, Manu ^w,ae   Silburn, Peter A ^af   Sohn, Young Ho ^ag   Stefanis, Leonidas ^x   Tadic, Vera ^v   Tomiyama, Hiroyuki ^q   Uitti, Ryan J ^a   Valente, Enza Maria ^o,ah   Vassilatis, Demetrios K ^x   Vilariño Güell, Carles ^ai   White, Linda R ^e   Wirdefeldt, Karin ^aj   Wszolek, Zbigniew K ^a   Wu, Ruey Meei ^y   Xiromerisiou, Georgia ^l,m   Maraganore, Demetrius M ^ak   Farrer, Matthew J ^ai   Ross, Owen A ^d   more..

^a MAYO CLINIC   (United States)

^b INSERM   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d MAYO GRADUATE SCHOOL   (United States)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^g GOETHE UNIVERSITY   (Germany)

^h MEDICAL UNIVERSITY OF SILESIA   (Poland)

ⁱ General Hospital of Syros   (Greece)

^j SAN GERARDO HOSPITAL   (Italy)

^k UNIV LILLE   (France)

^l UNIVERSITY OF THESSALY   (Greece)

^m INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

ⁿ LILLE UNIVERSITY HOSPITAL   (France)

^o CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^p THE MICHAEL J FOX FOUNDATION FOR PARKINSON'S RESEARCH   (United States)

^q JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r UNIVERSITY OF IOANNINA   (Greece)

^s STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t Seoul National University Hospital   (South Korea)

^u Hallym University   (South Korea)

^v UNIVERSITY OF LÜBECK   (Germany)

^w UNIVERSITY OF TÜBINGEN   (Germany)

^x BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^y NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^z UNIVERSITÉ PARIS DESCARTES   (France)

^aa HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^ab MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^ac GRIFFITH UNIVERSITY   (Australia)

^ad UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^ae UNIVERSITY OF TÜBINGEN   (Germany)

^af UNIVERSITY OF QUEENSLAND   (Australia)

^ag Yonsei University College of Medicine   (South Korea)

^ah UNIVERSITY OF SALERNO   (Italy)

^ai UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^aj KAROLINSKA INSTITUTE   (Sweden)

^ak NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

more..

Author keywords

Genetics; Interaction; LRRK2; MAPT; Parkinson's disease; SNCA

Indexed keywords

ALPHA SYNUCLEIN; LEUCINE RICH REPEAT KINASE 2; TAU PROTEIN;

ADULT; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LRRK2 GENE; MAJOR CLINICAL STUDY; MALE; MAPT GENE; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; SNCA GENE;

GENETICS; INTERACTION; LRRK2; MAPT; PARKINSON'S DISEASE; SNCA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; RISK; TAU PROTEINS; YOUNG ADULT;

EID: 84885187895     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.07.013     Document Type: Article

References (41)

1. Biernacka J.M., Armasu S.M., Cunningham J.M., Ahlskog J.E., Chung S.J., Maraganore D.M. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?. Parkinsonism Relat. Disord. 2011, 17:730-736.
2. Bower J.H., Maraganore D.M., McDonnell S.K., Rocca W.A. Incidence and distribution of parkinsonism in Olmstead County, Minnesota, 1976-1990. Neurology 1999, 52:1214-1220.
3. Chen L., Zhang S., Liu Y., Hong H., Wang H., Zheng Y., Zhou H., Chen J., Xian W., He Y., Li J., Liu Z., Pei Z., Zeng J. LRRK2 R1398H polymorphism is associated with decreased risk of Parkinson's disease in a Han Chinese population. Parkinsonism Relat. Disord. 2011, 17:291-292.
4. de Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 2006, 5:525-535.
5. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin. Trials 1986, 7:177-188.
6. Di Fonzo A., Wu-Chou Y.H., Lu C.S., van Doeselaar M., Simons E.J., Rohé C.F., Chang H.C., Chen R.S., Weng Y.H., Vanacore N., Breedveld G.J., Oostra B.A., Bonifati V. Acommon missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 2006, 7:133-138.
7. Elbaz A., Ross O.A., Ioannidis J.P., Soto-Ortolaza A.I., Moisan F., Aasly J., Annesi G., Bozi M., Brighina L., Chartier-Harlin M.C., Destée A., Ferrarese C., Ferraris A., Gibson J.M., Gispert S., Hadjigeorgiou G.M., Jasinska-Myga B., Klein C., Krüger R., Lambert J.C., Lohmnan K., van de Loo S., Loriot M.A., Lynch T., Mellick G.D., Mutez E., Nilsson C., Opala G., Puschmann A., Quattrone A., Sharma M., Silburn P.A., Stefanis L., Uitti R.J., Valente E.M., Vilariño-Güell C., Wirdefeldt K., Wszolek Z.K., Xiromerisiou G., Maraganore D.M., Farrer M.J. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann. Neurol. 2011, 69:778-792. Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.
8. Evans W., Fung H.C., Steele J., Eerola J., Tienari P., Pittman A., Silva R.d., Myers A., Vrieze F.W., Singleton A., Hardy J. The tau H2 haplotype is almost exclusively Caucasian in origin. Neurosci. Lett. 2004, 369:183-185.
9. Farrer M.J., Stone J.T., Lin C.H., Dächsel J.C., Hulihan M.M., Haugarvoll K., Ross O.A., Wu R.M. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat. Disord. 2007, 13:89-92.
10. Gasser T., Hardy J., Mizuno Y. Milestones in PD genetics. Mov. Disord. 2011, 26:1042-1048.
11. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 1999, 56:33-39.
12. Goodman S.N., Berlin J.A. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann. Intern. Med. 1994, 121:200-206.
13. Goris A., Williams-Gray C.H., Clark G.R., Foltynie T., Lewis S.J., Brown J., Ban M., Spillantini M.G., Compston A., Burn D.J., Chinnery P.F., Barker R.A., Sawcer S.J. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann. Neurol. 2007, 62:145-153.
14. Healy D.G., Abou-Sleiman P.M., Lees A.J., Casas J.P., Quinn N., Bhatia K., Hingorani A.D., Wood N.W. Tau gene and Parkinson's disease: a case-control study and meta-analysis. J.Neurol. Neurosurg. Psychiatry 2004, 75:962-965.
15. Heckman, M.G., Soto-Ortolaza, A.I., Aasly, J.O., Abahuni, N., Annesi, G., Bacon, J.A., Bardien, S., Bozi, M., Brice, A., Brighina, L., Carr, J., Chartier-Harlin, M.C., Dardiotis, E., Dickson, D.W., Diehl, N.N., Elbaz, A., Ferrarese, C., Fiske, B., Gibson, J.M., Gibson, R., Hadjigeorgiou, G.M., Hattori, N., Ioannidis, J.P., Boczarska-Jedynak, M., Jasinska-Myga, B., Jeon, B.S., Kim, Y.J., Klein, C., Kruger, R., Kyratzi, E., Lesage, S., Lin, C.H., Lynch, T., Maraganore, D.M., Mellick, G.D., Mutez, E., Nilsson, C., Opala, G., Park, S.S., Petrucci, S., Puschmann, A., Quattrone, A., Sharma, M., Silburn, P.A., Sohn, Y.H., Stefanis, L., Tadic, V., Theuns, J., Tomiyama, H., Uitti, R.J., Valente, E.M., Van Broeckhoven, C., van de Loo, S., Vassilatis, D.K., Vilariño-Güell, C., White, L.R., Wirdefeldt, K., Wszolek, Z.K., Wu, R.M., Hentati, F., Farrer M.J., Ross OA; on behalf of the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium., Population-specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO-PD) consortium. Mov. Disord. In press.
16. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
17. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinic-pathological study of 100 cases. J.Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
18. Nalls M.A., Plagnov V., Hernandez D.G., Sharma M., Sheerin U.M., Saad M., Simón-Sánchez J., Schulte C., Lesage S., Sveinbjörnsdóttir S., Stefánsson K., Martinez M., Hardy J., Heutink P., Brice A., Gasser T., Singleton A.B., Wood N.W. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377:641-649. International Parkinson Disease Genomics Consortium.
19. Krüger R., Vieira-Saecker A.M., Kuhn W., Berg D., Müller T., Kühnl N., Fichs G.A., Storch A., Hungs M., Woitalla D., Przuntek H., Epplen J.T., Schöls L., Riess O. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann. Neurol. 1999, 45:611-617.
20. Lill C.M., Roehr J.T., McQueen M.B., Kavvoura F.K., Bagade S., Schjeide B.M., Schjeide L.M., Meissner E., Zauft U., Allen N.C., Liu T., Schilling M., Anderson K.J., Beecham G., Berg D., Biernacka J.M., Brice A., DeStefano A.L., Do C.B., Eriksson N., Factor S.A., Farrer M.J., Foroud T., Gasser T., Hamza T., Hardy J.A., Heutink P., Hill-Burns E.M., Klein C., Latourelle J.C., Maraganore D.M., Martin E.R., Martinez M., Myers R.H., Nalls M.A., Pankratz N., Payami H., Satake W., Scott W.K., Sharma M., Singleton A.B., Stefansson K., Toda T., Tung J.Y., Vance J., Wood N.W., Zabetian C.P., Young P., Tanzi R.E., Khoury M.J., Zipp F., Lehrach H., Ioannidis J.P., Bertram L. Comprehensive research synopsis and systemic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet. 2012, 8:e10002548. 23andMe Genetic Epidemiology of Parkinson's Disease Consortium; International Parkinson's Disease Genomics Consortium, Parkinson's Disease GWAS Consortium; Welcome Trust Case Control Consortium 2 (WTCCC2)Parkinson's Disease GWAS Consortium; Welcome Trust Case Control Consortium 2 (WTCCC2).
21. Mamah C.E., Lesnick T.G., Lincoln S.J., Strain K.J., de Andrade M., Bower J.H., Ahlskog J.E., Rocca W.A., Farrer M.J., Maraganore D.M. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease. Ann. Neurol. 2005, 57:439-443.
22. Maraganore D.M., de Andrade M., Elbaz A., Farrer M.J., Ioannidis J.P., Krüger R., Rocca W.A., Schneider N.K., Lesnick T.G., Lincoln S.J., Hulihan M.M., Aasly J.O., Ashizawa T., Chartier-Harlin M.C., Checkoway H., Ferrarese C., Hadjigeorgiou G., Hattori N., Kawakami H., Lambert J.C., Lynch T., Mellick G.D., Papapetropoulus S., Parsian A., Quattrone A., Riess O., Tan E.K., Van Broeckhoven C. Collaborative analysis of alpha-synuclein gene promoter variability in Parkinson disease. JAMA 2006, 296:661-670. Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.
23. McCulloch C.C., Kay D.M., Factor S.A., Samii A., Nutt J.G., Higgins D.S., Griffith A., Roberts J.W., Leis B.C., Montimurro J.S., Zabetian C.P., Payami H. Exploring gene-environment interactions in Parkinson's disease. Hum. Genet. 2008, 123:257-265.
24. Mizuta I., Satake W., Nakabayashi Y., Ito C., Suzuki S., Momose Y., Nagai Y., Oka A., Inoko H., Fukae J., Saito Y., Sawabe M., Murayama S., Yamamoto M., Hattori N., Murata M., Toda T. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum. Mol. Genet. 2006, 15:1151-1158.
25. Mueller J.C., Fuchs J., Hofer A., Zimprich A., Lichtner P., Illig T., Berg D., Wüllner U., Meitinger T., Gasser T. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann. Neurol. 2005, 57:535-541.
26. Pankratz N., Wilk J.B., Latourelle J.C., DeStefano A.L., Halter C., Pugh E.W., Doheny K.F., Gusella J.F., Nichols W.C., Foroud T., Myers R.H. Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum. Genet. 2009, 124:593-605. PSG-PROGENI and GenePD Investigators, Coordinators and Molecular Genetic LaboratoriesCoordinators and Molecular Genetic Laboratories.
27. Postuma R.B., Montplaisir J. Predicting Parkinson's disease-why, when, and how?. Parkinsonism Relat. Disord. 2009, 15(suppl 3):S105-S109.
28. Ross O.A., Gosal D., Stone J.T., Lincoln S.J., Heckman M.G., Irvine G.B., Johnston J.A., Gibson J.M., Farrer M.J., Lynch T. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease. Mech. Aging Dev. 2007, 128:378-382.
29. Ross O.A., Wu Y.R., Lee M.C., Funayama M., Chen M.L., Soto A.I., Mata I.F., Lee-Chen G.J., Chen C.M., Tang M., Zhao Y., Hattori N., Farrer M.J., Tan E.K., Wu R.M. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann. Neurol. 2008, 64:88-92.
30. Ross O.A., Soto-Ortolaza A.I., Heckman M.G., Aasly J.O., Abahuni N., Annesi G., Bacon J.A., Bardien S., Bozi M., Brice A., Brighina L., Van Broeckhoven C., Carr J., Chartier-Harlin M.C., Dardiotis E., Dickson D.W., Diehl N.N., Elbaz A., Ferrarese C., Ferraris A., Fiske B., Gibson J.M., Gibson R., Hadjigeorgiou G.M., Hattori N., Ioannidis J.P., Jasinska-Myga B., Jeon B.S., Kim Y.J., Klein C., Kruger R., Kyratzi E., Lesage S., Lin C.H., Lynch T., Maraganore D.M., Mellick G.D., Mutez E., Nilsson C., Opala G., Park S.S., Puschmann A., Quattrone A., Sharma M., Silburn P.A., Sohn Y.H., Stefanis L., Tadic V., Theuns J., Tomiyama H., Uitti R.J., Valente E.M., van de Loo S., Vassilatis D.K., Vilariño-Güell C., White L.R., Wirdefeldt K., Wszolek Z.K., Wu R.M., Farrer M.J. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case control study. Lancet Neurol. 2011, 10:898-908. Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.
31. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., Tomiyama H., Nakashima K., Hasegawa K., Obata F., Yoshikawa T., Kawakami H., Sakoda S., Yamamoto M., Hattori N., Murata M., Nakamura Y., Toda T. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 2009, 41:1303-1307.
32. Simón-Sánchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., Krüger R., Federoff M., Klein C., Goate A., Perlmutter J., Bonin M., Nalls M.A., Illig T., Gieger C., Houlden H., Steffens M., Okun M.S., Racette B.A., Cookson M.R., Foote K.D., Fernandez H.H., Traynor B.J., Schreiber S., Arepalli S., Zonozi R., Gwinn K., van der Brug M., Lopez G., Chancock S.J., Schatzkin A., Park Y., Hollenbeck A., Gao J., Huang X., Wood N.W., Lorenz D., Deuschl G., Chen H., Riess O., Hardy J.A., Singleton A.B., Gasser T. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 2009, 41:1308-1312.
33. Skipper L., Wilkes K., Toft M., Baker M., Lincoln S., Hulihan M., Ross O.A., Hutton M., Aasly J., Farrer M.J. Linkage disequilibrium and association of MAPT H1 in Parkinson disease. Am. J. Hum. Genet. 2004, 75:669-677.
34. Tan E.K., Peng R., Teo Y.Y., Tan L.C., Angeles D., Ho P., Chen M.L., Lin C.H., Mao X.Y., Chang X.L., Prakash K.M., Liu J.J., Au W.L., Le W.D., Jankovic J., Burgunder J.M., Zhao Y., Wu R.M. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum. Mutat. 2010, 31:561-568.
35. Tobin J.E., Latourelle J.C., Lew M.F., Klein C., Suchowersky O., Shill H.A., Golbe L.I., Mark M.H., Growdon J.H., Wooten G.F., Racette B.A., Perlmutter J.S., Watts R., Guttman M., Baker K.B., Goldwurm S., Pezzoli G., Singer C., Saint-Hilaire M.H., Hendricks A.E., Williamson S., Nagle M.W., Wilk J.B., Massood T., Laramie J.M., DeStefano A.L., Litvan I., Nicholson G., Corbett A., Isaacson S., Burn D.J., Chinnery P.F., Pramstaller P.P., Sherman S., Al-hinti J., Drasby E., Nance M., Moller A.T., Ostergaard K., Roxburgh R., Snow B., Slevin J.T., Cambi F., Gusella J.F., Myers R.H. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology 2008, 71:28-34.
36. Trotta L., Guella I., Soldà G., Sironi F., Tesei S., Canesi M., Pezzoli G., Goldwurn S., Duga S., Asselta R. SNCA and MAPT genes: independent and joint effects in Parkinson disease in the Italian population. Parkinsonism Relat. Disord. 2012, 18:257-262.
37. Wang C., Cai Y., Zheng Z., Tang B.S., Xu Y., Wang T., Ma J., Chen S.D., Langston J.W., Tanner C.M., Chan P. Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants. Parkinsonism Relat. Disord. 2012, 18:958-963. Chinese Parkinson Study Group (CPSG).
38. Weinberg C.R. Applicability of the simple independent action model to epidemiologic studies involving two factors and a dichotomous outcome. Am. J. Epidemiol. 1986, 123:162-173.
39. Wider C., Vilariño-Güell C., Jasinska-Myga B., Heckman M.G., Soto-Ortolaza A.I., Cobb S.A., Aasly J.O., Gibson J.M., Lynch T., Uitti R.J., Wszolek Z.K., Farrer M.J., Ross O.A. Association of the MAPT locus with Parkinson's disease. Eur. J. Neurol. 2010, 17:483-486.
40. Wider C., Vilariño-Güell C., Heckman M.G., Jasinska-Myga B., Ortolaza-Soto A.I., Diehl N.N., Crook J.E., Cobb S.A., Bacon J.A., Aasly J.O., Gibson J.M., Lynch T., Uitti R.J., Wszolek Z.K., Farrer M.J., Ross O.A. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study. Eur. J. Neurol. 2011, 18:876-881.
41. Winkler S., Hagenah J., Lincoln S., Heckman M., Haugarvoll K., Lohmann-Hedrich K., Kostic V., Farrer M., Klein C. alpha-Synuclein and Parkinson disease susceptibility. Neurology 2007, 69:1745-1750.